Division of Digestive Diseases, Department of Medicine, Center for Ulcer Research and Education: Digestive Diseases Research Center David Geffen School of Medicine and Molecular Biology Institute, University of California, Los Angeles, California; and.
Am J Physiol Cell Physiol. 2014 Feb 1;306(3):C298-306. doi: 10.1152/ajpcell.00194.2013. Epub 2013 Dec 11.
To clarify the mechanism(s) underlying intracellular Ca(2+) concentration ([Ca(2+)]i) oscillations induced by an elevation in extracellular Ca(2+) concentration ([Ca(2+)]e) via the extracellular Ca(2+)-sensing receptor (CaR), we analyzed the pattern of [Ca(2+)]i response in multiple (2,303) individual HEK-293 cells transfected with the human CaR. An increase in the [Ca(2+)]e from 1.5 to 3 mM produced oscillatory fluctuations in [Ca(2+)]i in 70% of the cell population. To determine the role of PKC in the generation of [Ca(2+)]i oscillations, cells were exposed to increasing concentrations (0.5-5 μM) of the preferential PKC inhibitor Ro-31-8220 before stimulation by extracellular Ca(2+). Ro-31-8220 at 3-5 μM completely eliminated the [Ca(2+)]e-evoked [Ca(2+)]i oscillations and transformed the pattern to a peak and sustained plateau response. Treatment with other broad PKC inhibitors, including GFI or Gö6983, produced an identical response. Similarly, treatment with Ro-31-8220 or GFI eliminated [Ca(2+)]e-evoked [Ca(2+)]i oscillations in colon-derived SW-480 cells expressing the CaR. Treatment with inhibitors targeting classic PKCs, including Gö6976 and Ro-32-0432 as well as small interfering RNA-mediated knockdown of PKCα, strikingly reduced the proportion of cell displaying [Ca(2+)]e-evoked [Ca(2+)]i oscillations. Furthermore, none of the cells analyzed expressing a CaR mutant in which the major PKC phosphorylation site Thr(888) was converted to alanine (CaRT888A) showed [Ca(2+)]i oscillations after CaR activation. Our results show that [Ca(2+)]i oscillations induced by activation of the CaR in response to an increase in extracellular Ca(2+) or exposure to the calcimimetic R-568 result from negative feedback involving PKCα-mediated phosphorylation of the CaR at Thr(888).
为了阐明通过细胞外钙敏感受体(CaR)升高细胞外钙浓度([Ca(2+)]e)引起的细胞内钙浓度([Ca(2+)]i)振荡的机制,我们分析了转染人 CaR 的多个(2,303)个 HEK-293 细胞中[Ca(2+)]i 反应的模式。[Ca(2+)]e 从 1.5 增加到 3 mM 会导致 70%的细胞群体中[Ca(2+)]i 产生振荡波动。为了确定 PKC 在[Ca(2+)]i 振荡产生中的作用,在用细胞外钙刺激之前,细胞暴露于递增浓度(0.5-5 μM)的优选 PKC 抑制剂 Ro-31-8220。3-5 μM 的 Ro-31-8220 完全消除了[Ca(2+)]e 诱发的[Ca(2+)]i 振荡,并将模式转变为峰和持续平台反应。用其他广泛的 PKC 抑制剂(包括 GFI 或 Gö6983)处理产生相同的反应。同样,用 Ro-31-8220 或 GFI 处理消除了表达 CaR 的结肠衍生 SW-480 细胞中[Ca(2+)]e 诱发的[Ca(2+)]i 振荡。用靶向经典 PKC 的抑制剂(包括 Gö6976 和 Ro-32-0432)以及 PKCα 的小干扰 RNA 介导的敲低处理,显著降低了显示[Ca(2+)]e 诱发的[Ca(2+)]i 振荡的细胞比例。此外,在用 Thr(888)转化为丙氨酸的 CaR 突变体(CaRT888A)转染的分析细胞中,没有一个在 CaR 激活后显示[Ca(2+)]i 振荡。我们的结果表明,响应细胞外钙增加或暴露于钙敏感受体激动剂 R-568 激活 CaR 引起的[Ca(2+)]i 振荡是由 PKCα 介导的 Thr(888)磷酸化负反馈引起的。